Deadline’s Read the Screenplay series spotlighting the scripts behind the awards season’s most talked-about movies continues with Warner Bros‘ Sinners, written and directed by Ryan Coogler who ...

Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

Fintel reports that on December 3, 2025, Roth Capital initiated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. As of November 17, 2025, the average one-year price target for ...

BASH is a Unix shell and command language which can run Shell Script files. You do not need to install Ubuntu or any other Linux Distros unless your scripts need the ...

Fintel reports that on October 15, 2025, HC Wainwright & Co. reiterated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. Analyst Price Forecast Suggests 325.00% Upside As of ...

We recently published 10 Stocks Losing Big Amid Market Boom. Microbot Medical Inc. (NASDAQ:MBOT) is one of the worst performers on Thursday. Microbot extended its losing streak to a fourth consecutive ...

MBOT’s main value driver is its LIBERTY robot. This is a disposable, portable endovascular robot that has great potential. LIBERTY showed strong ACCESS-PVI data and now awaits FDA 510(k) clearance for ...

Microbot Medical Inc. (NASDAQ:MBOT), a medical device company with a market capitalization of $190 million, reported Monday it issued a total of 2,967,953 shares of its common stock from August 11 ...

Microbot Medical Inc. (MBOT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...

HINGHAM, Mass. - Microbot Medical Inc. (NASDAQ:MBOT), a developer of the LIBERTY Endovascular Robotic System, is actively preparing for the system’s anticipated U.S. launch projected for the third ...

Shares of Microbot Medical (NASDAQ:MBOT) rose in the premarket on Wednesday after the MedTech firm announced that a pivotal trial for its Liberty endovascular surgical robotic system reached the ...